Cargando…

Epidermal Growth Factor Protects Against High Glucose-Induced Podocyte Injury Possibly via Modulation of Autophagy and PI3K/AKT/mTOR Signaling Pathway Through DNA Methylation

AIM: Diabetic nephropathy (DN) is a serious health problem worldwide. Epidermal growth factor (EGF) has suggested as a potential biomarker for the progression of chronic kidney disease. In this study, we examined the effects of EGF on the high glucose (HG)-induced podocyte injury and explored the un...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yan, Deng, Ming, Ke, Xiao, Lei, Xiangyang, Ju, Hao, Liu, Zhiming, Bai, Xiaosu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149214/
https://www.ncbi.nlm.nih.gov/pubmed/34045875
http://dx.doi.org/10.2147/DMSO.S299562
_version_ 1783697916351741952
author Sun, Yan
Deng, Ming
Ke, Xiao
Lei, Xiangyang
Ju, Hao
Liu, Zhiming
Bai, Xiaosu
author_facet Sun, Yan
Deng, Ming
Ke, Xiao
Lei, Xiangyang
Ju, Hao
Liu, Zhiming
Bai, Xiaosu
author_sort Sun, Yan
collection PubMed
description AIM: Diabetic nephropathy (DN) is a serious health problem worldwide. Epidermal growth factor (EGF) has suggested as a potential biomarker for the progression of chronic kidney disease. In this study, we examined the effects of EGF on the high glucose (HG)-induced podocyte injury and explored the underlying molecular mechanisms. METHODS: The cell proliferation, toxicity, and cell apoptosis of podocytes were determined by CCK-8 assay, lactate dehydrogenase release assay, and flow cytometry, respectively, and protein levels in the podocytes were determined by Western blot assay. Mechanistically, DNA methylation analysis, bioinformatic analysis, methylation‑specific PCR and quantitative real-time PCR were used to analyze functional pathways in differentially methylated genes and the expression of the key methylated genes in the podocytes after different interventions. RESULTS: EGF treatment significantly increased the protein expression level of LC3 and decreased the protein level of P62 in HG-stimulated podocytes, which was attenuated by autophagy inhibitor, 3-methyladenine. EGF increased the cell proliferation and the protein expression levels of nephrin and synaptopodin, but reduced cell toxicity and cell apoptosis and protein expression level of cleaved caspase-3, which was partially antagonized by 3-methyladenine. DNA methylation expression profiles revealed the differential hypermethylation sites and hypomethylation sites among podocytes treated with normal glucose, HG and HG+EGF. GO enrichment analysis showed that DNA methylation was significantly enriched in negative regulation of phosphorylation, cell-cell junction and GTPase binding. KEGG pathway analysis showed that these genes were mainly enriched in PI3K-Akt, Hippo and autophagy pathways. Further validation studies revealed that six hub genes (ITGB1, GRB2, FN1, ITGB3, FZD10 and FGFR1) may be associated with the protective effects of EGF on the HG-induced podocyte injury. CONCLUSION: In summary, our results demonstrated that EGF exerted protective effects on HG-induced podocytes injury via enhancing cell proliferation and inhibiting cell apoptosis. Further mechanistic studies implied that EGF-mediated protective effects in HG-stimulated podocytes may be associated with modulation of autophagy and PI3K/AKT/mTOR signaling pathway.
format Online
Article
Text
id pubmed-8149214
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-81492142021-05-26 Epidermal Growth Factor Protects Against High Glucose-Induced Podocyte Injury Possibly via Modulation of Autophagy and PI3K/AKT/mTOR Signaling Pathway Through DNA Methylation Sun, Yan Deng, Ming Ke, Xiao Lei, Xiangyang Ju, Hao Liu, Zhiming Bai, Xiaosu Diabetes Metab Syndr Obes Original Research AIM: Diabetic nephropathy (DN) is a serious health problem worldwide. Epidermal growth factor (EGF) has suggested as a potential biomarker for the progression of chronic kidney disease. In this study, we examined the effects of EGF on the high glucose (HG)-induced podocyte injury and explored the underlying molecular mechanisms. METHODS: The cell proliferation, toxicity, and cell apoptosis of podocytes were determined by CCK-8 assay, lactate dehydrogenase release assay, and flow cytometry, respectively, and protein levels in the podocytes were determined by Western blot assay. Mechanistically, DNA methylation analysis, bioinformatic analysis, methylation‑specific PCR and quantitative real-time PCR were used to analyze functional pathways in differentially methylated genes and the expression of the key methylated genes in the podocytes after different interventions. RESULTS: EGF treatment significantly increased the protein expression level of LC3 and decreased the protein level of P62 in HG-stimulated podocytes, which was attenuated by autophagy inhibitor, 3-methyladenine. EGF increased the cell proliferation and the protein expression levels of nephrin and synaptopodin, but reduced cell toxicity and cell apoptosis and protein expression level of cleaved caspase-3, which was partially antagonized by 3-methyladenine. DNA methylation expression profiles revealed the differential hypermethylation sites and hypomethylation sites among podocytes treated with normal glucose, HG and HG+EGF. GO enrichment analysis showed that DNA methylation was significantly enriched in negative regulation of phosphorylation, cell-cell junction and GTPase binding. KEGG pathway analysis showed that these genes were mainly enriched in PI3K-Akt, Hippo and autophagy pathways. Further validation studies revealed that six hub genes (ITGB1, GRB2, FN1, ITGB3, FZD10 and FGFR1) may be associated with the protective effects of EGF on the HG-induced podocyte injury. CONCLUSION: In summary, our results demonstrated that EGF exerted protective effects on HG-induced podocytes injury via enhancing cell proliferation and inhibiting cell apoptosis. Further mechanistic studies implied that EGF-mediated protective effects in HG-stimulated podocytes may be associated with modulation of autophagy and PI3K/AKT/mTOR signaling pathway. Dove 2021-05-19 /pmc/articles/PMC8149214/ /pubmed/34045875 http://dx.doi.org/10.2147/DMSO.S299562 Text en © 2021 Sun et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Sun, Yan
Deng, Ming
Ke, Xiao
Lei, Xiangyang
Ju, Hao
Liu, Zhiming
Bai, Xiaosu
Epidermal Growth Factor Protects Against High Glucose-Induced Podocyte Injury Possibly via Modulation of Autophagy and PI3K/AKT/mTOR Signaling Pathway Through DNA Methylation
title Epidermal Growth Factor Protects Against High Glucose-Induced Podocyte Injury Possibly via Modulation of Autophagy and PI3K/AKT/mTOR Signaling Pathway Through DNA Methylation
title_full Epidermal Growth Factor Protects Against High Glucose-Induced Podocyte Injury Possibly via Modulation of Autophagy and PI3K/AKT/mTOR Signaling Pathway Through DNA Methylation
title_fullStr Epidermal Growth Factor Protects Against High Glucose-Induced Podocyte Injury Possibly via Modulation of Autophagy and PI3K/AKT/mTOR Signaling Pathway Through DNA Methylation
title_full_unstemmed Epidermal Growth Factor Protects Against High Glucose-Induced Podocyte Injury Possibly via Modulation of Autophagy and PI3K/AKT/mTOR Signaling Pathway Through DNA Methylation
title_short Epidermal Growth Factor Protects Against High Glucose-Induced Podocyte Injury Possibly via Modulation of Autophagy and PI3K/AKT/mTOR Signaling Pathway Through DNA Methylation
title_sort epidermal growth factor protects against high glucose-induced podocyte injury possibly via modulation of autophagy and pi3k/akt/mtor signaling pathway through dna methylation
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149214/
https://www.ncbi.nlm.nih.gov/pubmed/34045875
http://dx.doi.org/10.2147/DMSO.S299562
work_keys_str_mv AT sunyan epidermalgrowthfactorprotectsagainsthighglucoseinducedpodocyteinjurypossiblyviamodulationofautophagyandpi3kaktmtorsignalingpathwaythroughdnamethylation
AT dengming epidermalgrowthfactorprotectsagainsthighglucoseinducedpodocyteinjurypossiblyviamodulationofautophagyandpi3kaktmtorsignalingpathwaythroughdnamethylation
AT kexiao epidermalgrowthfactorprotectsagainsthighglucoseinducedpodocyteinjurypossiblyviamodulationofautophagyandpi3kaktmtorsignalingpathwaythroughdnamethylation
AT leixiangyang epidermalgrowthfactorprotectsagainsthighglucoseinducedpodocyteinjurypossiblyviamodulationofautophagyandpi3kaktmtorsignalingpathwaythroughdnamethylation
AT juhao epidermalgrowthfactorprotectsagainsthighglucoseinducedpodocyteinjurypossiblyviamodulationofautophagyandpi3kaktmtorsignalingpathwaythroughdnamethylation
AT liuzhiming epidermalgrowthfactorprotectsagainsthighglucoseinducedpodocyteinjurypossiblyviamodulationofautophagyandpi3kaktmtorsignalingpathwaythroughdnamethylation
AT baixiaosu epidermalgrowthfactorprotectsagainsthighglucoseinducedpodocyteinjurypossiblyviamodulationofautophagyandpi3kaktmtorsignalingpathwaythroughdnamethylation